Phase 3 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men aged 18 to 75 years old
- People whose prostate cancer has been confirmed by a tissue biopsy to be a specific type called adenocarcinoma
- People whose cancer has spread (metastasised) to other parts of the body, confirmed by imaging scans or biopsy
- People whose cancer has spread to distant lymph nodes, bones, or internal organs
- People whose prostate cancer has not previously been treated with local treatments such as radiation therapy or cryotherapy to the prostate
- People whose surgeon considers the prostate to be removable by surgery
Who may not be able to join:
- People whose surgeon considers the cancer cannot be surgically removed
- People whose life expectancy is estimated to be less than 2 years
- People who currently have active spinal cord compression
- People who have previously had local treatment for prostate cancer
- People who have difficulty swallowing, ongoing diarrhea, a bowel obstruction, or other conditions that may affect the ability to take or absorb medication
- People who are unwilling to sign the required consent forms
- People whom the trial investigator considers unsuitable for the trial for any reason (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lixin Hua, M.D., The First Affiliated Hospital with Nanjing Medical University
Phone: 13072564303
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
rPFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.